Session 1 - Perspectives: Future Demands in Analytical Practice
Session Chair: Michael P. Balogh, Waters Corporation |
The Anti-intellectual Effects of Intellectual Property |
Chris Lipinski, Scientific Advisor, Melior Discovery |
Accurate Mass Measurement of Small Molecules - The Past, The Present and The Exciting Future |
Anthony Bristow, AstraZeneca |
| |
|
Session 2 - Fundamental Topics in Structure Elucidation
Session Chair: David Stranz, Sierra Analytics |
| The Role of Structure Elucidation in Building and Evaluating Libraries of Bioactive Compounds from Marine Organisms |
Phil Crews |
| Using GC-MS, LC-MS and FT-ICR-MS Data for Structure Elucidation of Small Molecules |
Tobias Kind, UC Davis Genome Center-Metabolomics |
| Big Signals without Big Magnets: An Early Assessment of the Utility of Dynamic Nuclear Polarisation for Routine 13C and 15N NMR Spectroscopy |
Adrian L. Davis, Pfizer Global Research and Development |
Session 3 - Structure Elucidation-Applications and Problem Solving
Session Chair: David Stranz, Sierra Analytics |
| Efficient Multidisciplinary NMR and MS Structure Elucidation in the Age of High Sensitivity NMR |
David J. Detlefsen Ph.D., Novatia LLC |
| Higher Throughput Profiling of Drug Metabolites in Drug Discovery using High-Resolution Mass Spectrometry and Data Mining Techniques |
Mingshe Zhu Ph.D., Bristol-Myer Squibb Research and Development |
| FDA Forensic Investigations using Mass Spectrometry |
Bryan M. Gamble Ph.D., U.S. Food and Drug Administration, Forensic Chemistry Center |
Session 4 - The Science of Practical Chromatography
Session Chair: Nelu Grinberg, Boehringer-Ingelheim Pharmaceuticals, Inc. |
| The Need for Resolution (sometimes) in Bioanalytical LC-MS/MS Methodology |
Michael Donegan,Bristol-Myers Squibbh |
| Explaining Separation Phenomenon Through the use of Molecular Modeling and NMR |
Roy Helmy, Merck & Co |
| Mechanistix Aspects of Chiral Discrimination on Polysacharides Phases |
Nelu Grinberg, Boehringer-Ingelheim Pharmaceuticals, Inc.. |
| Session 5 - Atmospheric Ionization Technologies: Where are we now? |
| |
|
Panelists:
Justin Wiseman, Prosolia
- Presentaion not available
Chuck McEwen, DuPont Corporate Center for Analytical Science
Yeping Zhao, Roche |
|
Excellence In Science Award Winner
Yeping Zhao, Roche |
|
|